Metabolic Profiling in Human Fibroblasts Enables Subtype Clustering in Glycogen Storage Disease
Open Access
- 23 November 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 11
Abstract
Glycogen storage disease subtypes I and III (GSD I and GSD III) are monogenic inherited disorders of metabolism that disrupt glycogen metabolism. Unavailability of glucose in GSD I and induction of gluconeogenesis in GSD III modify energy sources and possibly, mitochondrial function. Abnormal mitochondrial structure and function were described in mice with GSD Ia, yet significantly less research is available in human cells and ketotic forms of the disease. We hypothesized that impaired glycogen storage results in distinct metabolic phenotypes in the extra- and intracellular compartments that may contribute to pathogenesis. Herein, we examined mitochondrial organization in live cells by spinning-disk confocal microscopy and profiled extra- and intracellular metabolites by targeted LC-MS/MS in cultured fibroblasts from healthy controls and from patients with GSD Ia, GSD Ib, and GSD III. Results from live imaging revealed that mitochondrial content and network morphology of GSD cells are comparable to that of healthy controls. Likewise, healthy controls and GSD cells exhibited comparable basal oxygen consumption rates. Targeted metabolomics followed by principal component analysis (PCA) and hierarchical clustering (HC) uncovered metabolically distinct poises of healthy controls and GSD subtypes. Assessment of individual metabolites recapitulated dysfunctional energy production (glycolysis, Krebs cycle, succinate), reduced creatinine export in GSD Ia and GSD III, and reduced antioxidant defense of the cysteine and glutathione systems. Our study serves as proof-of-concept that extra- and intracellular metabolite profiles distinguish glycogen storage disease subtypes from healthy controls. We posit that metabolite profiles provide hints to disease mechanisms as well as to nutritional and pharmacological elements that may optimize current treatment strategies.Keywords
This publication has 34 references indexed in Scilit:
- The MMACHC proteome: Hallmarks of functional cobalamin deficiency in humansMolecular Genetics and Metabolism, 2011
- Quiescent Fibroblasts Exhibit High Metabolic ActivityPLOS Biology, 2010
- Glycogen Storage Disease Type III diagnosis and management guidelinesGenetics in Medicine, 2010
- Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and TurkeyJournal of Human Genetics, 2006
- Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle.Journal of Clinical Investigation, 1996
- Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c.Journal of Clinical Investigation, 1995
- Mutations in the Glucose-6-Phosphatase Gene that Cause Glycogen Storage Disease Type 1aScience, 1993
- Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type IIIThe Journal of Pediatrics, 1990
- Neutropenia and impaired neutrophil migration in type IB glycogen storage diseaseThe Journal of Pediatrics, 1980
- The Subgroups of Type III GlycogenosisEuropean Journal of Biochemistry, 1967